Better Science, Better Lives: Women's Health Research at Yale is Working for You
Across the country, it’s becoming clearer every day: We must study the health of women. We must study the influence of sex-and-gender differences on health. And it’s time for all aspects of medical research and practice to embrace this change.
YSPH Convenes Experts to Examine Alcohol’s Role in Cancer
Chronic alcohol abuse is considered to be an important risk factor for disease worldwide. In addition, alcohol and its metabolite, acetaldehyde, are recognized as carcinogens that contribute to four percent of cancer deaths. Although scientific studies began to show this association over 100 years ago, the role of alcohol in chronic diseases such as cancer is still not well understood by the public and medical professionals. The 4th International Conference on Alcohol and Cancer was organized by Vasilis Vasiliou, PhD, the Susan Dwight Bliss Professor of Epidemiology, sponsored by the Department of Environmental Health Sciences of the Yale School of Public Health, and supported by an R13 grant from the National Institute of Alcohol Abuse and Alcoholism (NIAAA). The conference, held in Newport, R.I., brought together 75 international scholars with special interest in alcohol and/or cancer.
Le Zhang, PhD Wins Avenir Award for Research on Substance Use Disorders and HIV/AIDS
Assistant Professor Le Zhang, PhD was recently awarded a DP2 grant from the National Institutes of Health (NIH), entitled “Immune Network Dysregulation of the Central Nervous System with HIV Persistence and Opioid Abuse.” The grant, which amounts to more than $2.5 million, began on May 15, 2022 and lasts for four years.
Patients with Opioid Use Disorder Treated in Emergency Departments Shed Light on Their Unmet Needs and Opportunities to Improve Care in Yale-Led Study Published in JAMA Network Open
To better understand the experiences of patients with OUD on receiving care in the ED and to identify opportunities to improve care, Yale researchers led a collaboration with New York University, John’s Hopkins University, University of Cincinnati, Mount Sinai Hospital in New York, and the University of Washington. Between June 2018 and January 2019. They conducted focus groups with ED patients across six academic, community, and public safety net EDs in Baltimore, MD, Cincinnati, OH, New York City, NY, Seattle, WA and Claremont, NH, as part of two NIDA Clinical Trials Network studies.
Stressed Out and Locked-Down During Pandemic, New Yorkers Craved Alcohol, YSPH Study Finds
As New York state’s lockdown orders wore on in the early months of the COVID-19 pandemic, residents increasingly felt cravings for alcohol — and reported subsequently misusing it, a new study from scientists at the Yale School of Public Health and Stony Brook University has found.
Here’s how Connecticut can move beyond the harm of the War on Drugs
In the 1990s, then-Senator Joe Biden and others pushed a War on Drugs, a war that had a tremendous negative impact on our state. Prison populations soared; over a third of young men of color were under criminal justice supervision; and drug use and attendant public health consequences proceeded unabated.Source: CT Mirror
Pandemic-based Approach to Methadone Treatment Restrictions Should Remain, YSPH Study Finds
When the COVID-19 pandemic ripped through New England and the rest of the United States in early 2020, substance use disorder treatment centers were forced to make massive changes to minimize the spread of coronavirus.
The Overdose Crisis: Harm Reduction in U.S. Health Policy
On May 20, Yale’s Department of Internal Medicine and Program in Addiction Medicine hosted its first event on Clubhouse, a social networking app that allows members to gather in audio chat rooms and discuss issues in a live podcast style. The event focused on the drug overdose in the United States and incorporation of harm reduction into U.S. health policy and practice.
WHRY Funds Studies on Heart Disease, Insomnia, and Pain
Women’s Health Research at Yale today announced funding for three new studies investigating a method for improving the diagnosis of heart disease in women, a therapy for clinically significant sleep disruption common in Black women, and the influence of biological sex on the underlying brain patterns that link pain and opioid use.
Addiction Psychiatry Division Will Participate in Consortium to Develop New Treatment Tools for Addiction
Yale School of Medicine’s Division of Addiction Psychiatry will participate in a consortium funded by a multimillion-dollar federal grant that will attempt to develop new treatment tools for addiction.
Op-Ed: Yale study on lung disease forecasts dire consequences for flavor bans
A new study from Yale School of Public Health should serve as a warning to e-cigarette opponents and public health officials pushing e-cigarette flavor bans and restrictions around the country. The Yale research revealed that higher levels of e-cigarette and marijuana use did not result in higher rates of e-cigarette or vaping-related lung injuries (EVALI). EVALI made headlines during 2019 and was responsible for at least 2,800 hospitalizations and 68 deaths.Source: The Center Square
Large Genetic Study Expands Links Between DNA Variations and Problematic Drinking
A genome-wide analysis of over 435,000 individuals of European ancestry has revealed 19 new locations in the human genome where common DNA variations significantly raise risk for problematic drinking. It also linked pathological drinking with elevated risk of many psychiatric disorders, including depression and schizophrenia.Source: Brain & Behavior Research Foundation